References
- Bilati U, Allemann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm, 2005;59:375–88
- Collier HJ, Dinneen JC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Brit J Pharm Chemoth, 1998;32:295–310
- Dai C, Wang B, Zhao H. Microencapsulation peptide and protein drugs delivery system. Colloids Surf B Biointerfaces, 2005;41:117–23
- Giannuzzo M, Feeney M, Corrente F, Paoletti L, Paolicelli P, Tita B, Vitali F, Casadei MA. pH-sensitive hydrogels of dextran: Synthesis, characterization and in vivo studies. J Drug Target, 2008;16:649–59
- Gupta P, Vermani K, Garg S. Hydrogels: From controlled release to pH-responsive drug delivery. Drug Discov Today, 2002;7:569–79
- Hamidi M, Azadi A, Rafiei P. Hydrogels nanoparticles in drug delivery. Adv Drug Deliv Rev, 2008;60:1638–49
- He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm, 1998;166:75–88
- Kim SH, Chu CC. Synthesis and characterization of dextran methacrylate hydrogels and structural studies by SEM. J Biomed Mater Res, 2000;49:517–27
- Koane DS. Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng, 2007;96:203–9
- Koster R, Anderson M, De-Beer EJ. Acetic acid analgesic screen. Fed Proc, 1959;18:418–20
- Majeti NV, Kumar R. Nano and microparticles as controlled drug delivery devices. J Pharm Sci, 2000;3:234–58
- Mana Z, Pellequer Y, Lamprecht A. Oil-in-oil micro-encapsulation technique with an external perfluorohexane phase. Int J Pharm, 2007;338:231–7
- Morita T, Sakamura Y, Horikiri Y, Suzuki T, Yoshino H. Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using polyethylene glycol) as a protein micronization adjuvant. J Control Release, 2000;69:435–44
- Muzzalupo R, Iemma F, Picci N, Pitarresi G, Cavallaro G, Giammona G. Novel water-swellable beads based on acryloylated polyaspartamide. Colloid Polym Sci, 2001;279:688–95
- O’Hagan DT, Singh M, Ulmer JB. Microparticles for the delivery of DNA vaccines. Immunol Rev, 2004;199:191–200
- Pitarresi G, Pierro P, Giammona G, Iemma F, Muzzalupo R, Picci N. Drug release from α,β-polyN-2-hydroxyethyl)-dl-aspartamide-based microparticles. Biomaterials, 2004;25:4333–43
- Prokop A, Davidson JM. Nanovehicular intracellular delivery systems. J Pharm Sci, 2008;97:3518–90
- Rosca ID, Watari F, Uo M. Microparticles formation and its mechanism in single and double emulsion solvent evaporation. J Control Release, 2004;99:271–80
- Rossi S, Ferrari F, Bonferoni MC, Caramella C. Characterization of chitosan hydrochloride–mucin interaction by means of viscosimetric and turbidimetric measurements. Eur J Pharm Sci, 2000;10:251–7
- Schoubben A, Blasi P, Giovagnoli S, Perioli L, Rossi C, Ricci M. Novel composite microparticles for protein stabilization and delivery. Eur J Pharm Sci, 2009;36:226–34
- Trotta M, Chirio D, Cavalli R, Peira E. Hydrophilic microspheres from water-in-oil emulsion by the water diffusion technique. Pharm Res, 2004;21:1145–9
- Van Dijk-Wolthuis WNE, Ketteness-Van Den Bosch JJ, Van Der Kerk-Van Hoof A, Hennink WE. Reaction of dextran with glycidyl methacrylate: An unexpected transesterification. Macromolecules, 1997;30:3411–13
- Yu CY, Yin BC, Zhang W, Cheng SX, Zhang XZ, Zhuo RX. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. Colloids Surf B Biointerfaces, 2009;68:245–9
- Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain, 1983;16:109–10